Ajanta Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,048	1,751	1,295	3,298	2,064
Short-Term Investments	5,599	-	-	-	-
Trading Asset Securities	-	4,387	3,301	5,103	1,219
Cash & Short-Term Investments	6,646	6,139	4,595	8,401	3,282
Cash Growth	8.27%	33.58%	-45.30%	155.96%	-13.21%
Accounts Receivable	18,539	11,827	12,468	10,569	10,198
Other Receivables	-	412	696.6	459.2	460.5
Receivables	18,556	12,265	13,505	11,202	10,722
Inventory	9,385	9,039	8,284	8,156	7,911
Prepaid Expenses	-	245.8	259.2	164.4	155.8
Other Current Assets	2,767	742.7	666.4	416.2	573.6
Total Current Assets	37,354	28,430	27,309	28,340	22,645
Property, Plant & Equipment	20,834	18,918	17,210	16,982	16,474
Long-Term Investments	285	284.4	227.4	290	294.2
Other Intangible Assets	415.8	465.2	146.6	77.5	90.2
Long-Term Deferred Tax Assets	1,886	1,864	1,345	967.7	555.5
Other Long-Term Assets	773.2	187.6	146.4	133.4	497.1
Total Assets	61,548	50,150	46,384	46,790	40,556
Accounts Payable	5,443	4,542	4,632	4,228	3,272
Accrued Expenses	303.9	892.1	671.3	356.8	375.9
Short-Term Debt	2,120	60.9	30.5	38.4	94.9
Current Portion of Leases	87.6	101.1	102.7	94.3	64.6
Current Income Taxes Payable	54.9	405.3	447.7	330.7	79.4
Current Unearned Revenue	-	3.3	3.3	3.3	3.3
Other Current Liabilities	6,148	3,956	3,070	6,342	2,584
Total Current Liabilities	14,158	9,961	8,958	11,393	6,474
Long-Term Leases	394.2	347.2	235.2	262	185.7
Long-Term Unearned Revenue	-	20	23.4	26.7	30
Pension & Post-Retirement Benefits	-	468.6	135	23.2	-
Long-Term Deferred Tax Liabilities	1,179	1,105	1,085	977.2	1,019
Other Long-Term Liabilities	546.4	344.6	274.1	228.4	204.1
Total Liabilities	16,278	12,247	10,710	12,910	7,912
Common Stock	250.7	249.8	251.8	251.8	170.8
Additional Paid-In Capital	-	36.6	1.8	-	-
Retained Earnings	-	37,434	35,254	33,523	32,495
Comprehensive Income & Other	45,020	182.1	166.2	105	-22.1
Shareholders' Equity	45,271	37,903	35,674	33,880	32,643
Total Liabilities & Equity	61,548	50,150	46,384	46,790	40,556
Total Debt	2,602	509.2	368.4	394.7	345.2
Net Cash (Debt)	4,045	5,629	4,227	8,006	2,937
Net Cash Growth	-28.15%	33.17%	-47.20%	172.60%	-13.73%
Net Cash Per Share	32.37	44.97	33.55	62.49	22.65
Filing Date Shares Outstanding	124.92	125.68	126.68	125.91	128.12
Total Common Shares Outstanding	124.92	125.68	126.68	125.91	128.12
Working Capital	23,197	18,469	18,352	16,947	16,171
Book Value Per Share	362.40	301.59	281.60	269.07	254.78
Tangible Book Value	44,855	37,438	35,527	33,802	32,553
Tangible Book Value Per Share	359.08	297.88	280.44	268.45	254.08
Land	-	1,467	1,488	1,577	1,575
Buildings	-	8,113	6,174	6,057	5,870
Machinery	-	16,364	14,692	13,879	13,276
Construction In Progress	-	1,763	2,565	2,095	1,529
Leasehold Improvements	-	-	-	-	10.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.